Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation
NCT03087487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 466991
Last updated 2025-06-25
Summary
The primary objectives of this study are to compare the risk of major bleeding and stroke/systemic embolism (SE) events among oral anticoagulant (OAC)-naïve non-valvular atrial fibrillation (NVAF) patients initiating OAC warfarin or apixaban or dabigatran or rivaroxaban treatment.
Conditions
- Non-Valvular Atrial Fibrillation
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-01
- Primary Completion
- 2023-02-26
- Completion
- 2023-03-08
Countries
- United States
Study Locations
More Related Trials
-
Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter
NCT01839357 ·Status: COMPLETED ·Phase: PHASE3
-
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
NCT02919982 ·Status: COMPLETED
-
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
NCT01877915 ·Status: COMPLETED ·Phase: PHASE3
-
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
NCT06108414 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation
NCT06433479 ·Status: COMPLETED ·Phase: NA
-
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
NCT01483183 ·Status: TERMINATED ·Phase: PHASE1
-
Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients
NCT04128878 ·Status: COMPLETED
-
Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation
NCT05469308 ·Status: UNKNOWN ·Phase: NA
-
An Exploratory stuDy of effectIveneSs and Safety of rivarOxaban in Patients With Left VEntricular Thrombus (R-DISSOLVE)
NCT04970381 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Study of Oral K201 for Prevention of AF Recurrence
NCT01067833 ·Status: TERMINATED ·Phase: PHASE2
-
Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion
NCT04195997 ·Status: UNKNOWN ·Phase: PHASE4
-
RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial
NCT02303795 ·Status: COMPLETED ·Phase: PHASE2
-
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
NCT04747496 ·Status: COMPLETED
-
Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban)
NCT03455439 ·Status: COMPLETED
-
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
NCT01055912 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm
NCT00007605 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation
NCT05804747 ·Status: COMPLETED
-
Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
NCT04684056 ·Status: UNKNOWN
-
DOAC in Chinese Patients With Atrial Fibrillation
NCT05378035 ·Status: RECRUITING
-
A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
NCT02069119 ·Status: COMPLETED ·Phase: PHASE1
-
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
NCT00526136 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty
NCT04743063 ·Status: UNKNOWN
-
RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care
NCT07187570 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation
NCT03367325 ·Status: UNKNOWN ·Phase: NA
-
Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output
NCT04206865 ·Status: WITHDRAWN ·Phase: PHASE4